Glasgow JN - Search Results

1

A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration.

van de Ven R, Scheffer GL, Reurs AW, Lindenberg JJ, Oerlemans R, Jansen G, Gillet JP, Glasgow JN, Pereboev A, Curiel DT, Scheper RJ, de Gruijl TD. van de Ven R, et al. Among authors: glasgow jn. Blood. 2008 Sep 15;112(6):2353-9. doi: 10.1182/blood-2008-03-147850. Epub 2008 Jul 14. Blood. 2008. PMID: 18625884 Free PMC article.

2

Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.

Van Houdt WJ, Wu H, Glasgow JN, Lamfers ML, Dirven CM, Gillespie GY, Curiel DT, Haviv YS. Van Houdt WJ, et al. Among authors: glasgow jn. Neuro Oncol. 2007 Jul;9(3):280-90. doi: 10.1215/15228517-2007-017. Epub 2007 May 23. Neuro Oncol. 2007. PMID: 17522331 Free PMC article.

3

A strategy for adenovirus vector targeting with a secreted single chain antibody.

Glasgow JN, Mikheeva G, Krasnykh V, Curiel DT. Glasgow JN, et al. PLoS One. 2009 Dec 21;4(12):e8355. doi: 10.1371/journal.pone.0008355. PLoS One. 2009. PMID: 20027223 Free PMC article.

4

Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.

Perreau M, Mennechet F, Serratrice N, Glasgow JN, Curiel DT, Wodrich H, Kremer EJ. Perreau M, et al. Among authors: glasgow jn. J Virol. 2007 Apr;81(7):3272-84. doi: 10.1128/JVI.01530-06. Epub 2007 Jan 17. J Virol. 2007. PMID: 17229706 Free PMC article.

5

A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.

Thacker EE, Nakayama M, Smith BF, Bird RC, Muminova Z, Strong TV, Timares L, Korokhov N, O'Neill AM, de Gruijl TD, Glasgow JN, Tani K, Curiel DT. Thacker EE, et al. Among authors: glasgow jn. Vaccine. 2009 Nov 23;27(50):7116-24. doi: 10.1016/j.vaccine.2009.09.055. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786146 Free PMC article.

6

Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.

Preuss MA, Glasgow JN, Everts M, Stoff-Khalili MA, Wu H, Curiel DT. Preuss MA, et al. Among authors: glasgow jn. Open Gene Ther J. 2008 Jan 1;1:7-11. doi: 10.2174/1875037000801010007. Open Gene Ther J. 2008. PMID: 19834585 Free PMC article.

7

Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy.

Breidenbach M, Rein DT, Everts M, Glasgow JN, Wang M, Passineau MJ, Alvarez RD, Korokhov N, Curiel DT. Breidenbach M, et al. Among authors: glasgow jn. Gene Ther. 2005 Jan;12(2):187-93. doi: 10.1038/sj.gt.3302404. Gene Ther. 2005. PMID: 15526007

8

Transductional targeting of adenovirus vectors for gene therapy.

Glasgow JN, Everts M, Curiel DT. Glasgow JN, et al. Cancer Gene Ther. 2006 Sep;13(9):830-44. doi: 10.1038/sj.cgt.7700928. Epub 2006 Jan 27. Cancer Gene Ther. 2006. PMID: 16439993 Free PMC article. Review.

9

An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.

Murakami M, Ugai H, Wang M, Belousova N, Dent P, Fisher PB, Glasgow JN, Everts M, Curiel DT. Murakami M, et al. Among authors: glasgow jn. Virology. 2010 Nov 25;407(2):196-205. doi: 10.1016/j.virol.2010.08.010. Epub 2010 Sep 9. Virology. 2010. PMID: 20828776 Free article.

10

A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene.

Haviv YS, Takayama K, Glasgow JN, Blackwell JL, Wang M, Lei X, Curiel DT. Haviv YS, et al. Among authors: glasgow jn. Mol Cancer Ther. 2002 Mar;1(5):321-8. Mol Cancer Ther. 2002. PMID: 12489848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters